Lisa Saiman, MD, MPH

Board Certifications: 
Pediatric Infectious Diseases, Pediatrics
Treats Children
Profile Headshot

Overview

Academic Appointments

  • Professor of Pediatrics at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Languages

  • Spanish

Gender

  • Female

Location(s)

CUMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Albert Einstein College of Medicine - Yeshiva University
  • Internship: Babies & Children's Hospital - Columbia Presbyterian Medical Center
  • Residency: Babies & Children's Hospital - Columbia Presbyterian Medical Center
  • Fellowship: Babies & Children's Hospital - Columbia Presbyterian Medical Center

Board Certifications

  • Pediatric Infectious Diseases
  • Pediatrics
America's Top Doctor
NY Top Doctor

Research

Grants

INCIDENCE OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HOSPITALIZED ADULTS AND EVALUATION OF CHANGE IN FUNCTIONAL STATUS ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS INFECTION HOSPITALIZATION (P&S Industry Clinical Trial)

Nov 8 2017 - Dec 1 2022

FLU SAFE: FLU SMS ALERTS TO FREEZE EXPOSURE (Federal Gov)

Dec 9 2016 - Nov 30 2020

TRAINING IN PEDIATRIC INFECTIOUS DISEASE (Federal Gov)

Sep 1 2014 - Aug 31 2019

THE SAFETY OF RED BLOOD CELL TRANSFUSIONS (Federal Gov)

Jul 1 2014 - Dec 31 2018

PEDIATRIC AMBULATORY HEALTHCARE ASSOCIATED INFECTIONS: INCIDENCE RATES, RISK FACTORS, OUTCOMES, COSTS AND ALGORITHMS FOR DETECTION (Federal Gov)

Sep 30 2015 - Sep 29 2018

PEDIATRIC AMBULATORY HEALTHCARE ASSOCIATED INFECTIONS: INCIDENCE RATES, RISK FACTORS, OUTCOMES, COSTS AND ALGORITHMS FOR DETECTION (Federal Gov)

Sep 30 2015 - Sep 29 2018

MOSAIC: MOBILE SURVEILLANCE FOR ARI AND ILI IN THE COMMUNITY (Federal Gov)

Sep 30 2012 - Sep 29 2018

IMPROVING IMPLEMENTATION OF INFECTION PREVENTION/CONTROL IN CF COMMUNITIES (Private)

Sep 1 2015 - Aug 31 2018

OPTIMIZING - TREATMENT FOR EARLY PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS: THE OPTIMIZE MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED TRAIL (Federal Gov)

Sep 15 2013 - Jun 30 2018

MULTICENTER STUDY ASSESSING KNOWLEDGE, ATTITUDES, AND PRACTICES OF PEOPLE WITH CF REGARDING SAFETY MONITORING IN CF CLINICAL TRIALS (Private)

Jan 1 2017 - Dec 31 2017

INFLUENZA AND OTHER RESPIRATORY VIRAL DISEASE IN PEDIATRIC CHRONIC CARE FACILITIES INFECTION CONTRO (Federal Gov)

Aug 3 2015 - Aug 2 2017

PATIENT AND PARENT UNDERSTANDING OF SAFETY MONITORING IN CF CLINICAL TRIALS (Private)

Jul 1 2016 - Jun 30 2017

PROSPECTIVE TRIAL OF ORAL AZITHROMYCIN WHEN ADDED TO INHALED TOBRAMYCIN IN CF (Federal Gov)

Jul 1 2016 - Jun 30 2017

KEEP IT CLEAN FOR KIDS: THE KICK PROJECT (Federal Gov)

Jul 1 2012 - Jun 30 2017

TRENDING AND MODELING MULTI-DRUG RESISTANT ORGANISMS IN THE NEONATAL INTENSIVE CARE UNIT (Private)

Oct 1 2014 - Sep 30 2016

PEDIATRIC AMBULATORY HEALTHCARE ASSOCIATED INFECTIONS: INCIDENCE RATES, RISK FACTORS, OUTCOMES, COSTS AND ALGORITHMS FOR DETECTION (Federal Gov)

Sep 30 2015 - Sep 29 2016

REDUCING MULTIDRUG-RESISTANT ORGANISMS (MDRO) AND CLOSTRIDIUM DIFFICILE INFECTIONS (CDI) BY IMPROVING ENVIRONMENTAL CLEANING, ANTIMICROBIAL STEWARDSHIP, AND EDUCATION (REALISE) (NY State Gov)

Apr 1 2013 - Mar 31 2016

THE EPIDEMIOLOGY OF NOVEL INFLUENZA VIRUS INFECTION AND EVALUATION OF ANTIVIRAL AND VACCINE EFFECTIVENESS (Federal Gov)

Apr 14 2015 - Sep 18 2015

OPTIMIZING TREATMENT EARLY PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS (Federal Gov)

Sep 15 2013 - Jun 30 2015

POPULATION PHARMACOKINETICS OF MEROPENEM IN CHILDREN WITH CYSTIC FIBROSIS: JUSTIFYING HIGH-DOSE, PROLONGED INFUSION REGIMENS (Private)

Mar 23 2012 - Sep 1 2014

IMPROVING ANTIMICROBIAL PRESCRIBING PRACTICES IN THE NEONATAL INTENSIVE CARE UNIT (Federal Gov)

Jul 24 2008 - Oct 30 2013

THE STEP PROJECT (STOPPING TRANSMISSION IS EVERYONE''S PRIORI TY) (Private)

Jan 1 2012 - Dec 31 2012

MANAGEMENT OF BACTERIAL AIR CONTAMINATION IN CF CLINICAL (Private)

Oct 11 2010 - Dec 31 2012

CATHETER DWELL TIME AND RISK OF BLOODSTREAM INFECTIONS IN HO SPITALIZED NEONATES (Federal Gov)

Sep 30 2010 - Jul 31 2012

GASTROINTESTINAL TRACT OF NEONATES: A PILOT STUDY (Private)

Jul 1 2008 - Jun 30 2012

CHARACTERIZATION AND IMPACT OF MRSA INFECTION/COLONIZATION I N CYSTIC FIBROSIS (Private)

Oct 1 2008 - Mar 31 2012

POLYMYIN-RESISTANT PSEUDOMONAS IN CF LUNG INFECTION (Federal Gov)

Jul 1 2009 - Feb 29 2012

POLMYXIN-RESISTANT PSEUDOMONAS IN CF LUNG INFECTION (Federal Gov)

Apr 1 2007 - Mar 31 2011

APPLIED RESEARCH IN ANTIMICROBIAL RESISTANCE: STUDIES OF SUS CEPTIBILITY TESTING (Federal Gov)

Sep 30 2007 - Sep 29 2010

CF REFERRAL CF REFERRAL CENTER FOR SUSCEPTIBILITY AND SYNERG Y TESTING OF MULTIDRUG-RESISTANT ORGANIS (Private)

Jul 1 2005 - Apr 30 2010

INTERDISCIPLINARY RESEARCH:ANTIMICROBIAL RESISTANCE(RMI) (Federal Gov)

Sep 20 2004 - Jul 31 2009

INFECTION CONTROL AND MICROBIOLOGY PRACTICES IN CYSTIC FIBROSIS (Private)

Apr 1 2003 - Dec 31 2005